


| Key | % Net Assets |
|---|---|
| 5.2% | |
| 4.9% | |
| 4.6% | |
| 4.5% | |
| 80.8% |
| Name | % Net Assets |
|---|---|
| Royal Dutch Shell 'B' | 5.2% |
| BP | 4.9% |
| British American Tobacco | 4.6% |
| HSBC | 4.5% |
| Vodafone | 3.8% |
| GlaxoSmithKline | 3.7% |
| AstraZeneca | 3.6% |
| Centrica | 3.2% |
| Aviva | 3.0% |
| Standard Chartered | 2.9% |
No asset data available.
| Date | 23-Jun-2023 |
|---|---|
| NAV | 241.38p |
| Currency | GBP |
| Change | -1.20p |
| % | -0.49% |
| YTD change | 241.38p |
| YTD % | n/a |
| Fund Inception | n/a |
|---|---|
| Fund Manager | Pan European Equities Team |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | £500 |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 0.75% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.01 |
| Sharpe ratio | 0.13 |
You are here: research